• China SXT Pharmaceuticals will consolidate Class A and Class B ordinary shares in a 1-for-80 reverse split effective Aug. 10, 2026.
• Class A shares set to trade on a post-consolidation basis at the market open Aug. 10 under SXTC; new CUSIP G2161P173.
• Class A shares outstanding expected to fall to about 1,321,301 from 105,704,077; fractional shares to be rounded up.
• Outstanding stock options, warrants, and other purchase rights to Class A shares to be adjusted proportionately.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608050900PRIMZONEFULLFEED9804137) on August 05, 2026, and is solely responsible for the information contained therein.